Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New psoriasis drug tracked in everyday patients

NCT ID NCT06701513

Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 350 adults in France with moderate-to-severe plaque psoriasis who are starting deucravacitinib, a daily pill. Researchers will track how well the drug controls skin symptoms and improves quality of life over time in real-world settings, not a controlled lab environment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Deucravacitinib
What this could lead to
If successful, this study could confirm that deucravacitinib works well in everyday practice for controlling moderate-to-severe plaque psoriasis.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by factors like patient selection or adherence. It does not test a new drug, only tracks how it performs in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients who have been diagnosed with moderate-to-severe plaque psoriasis and who intend to start deucravacitinib treatment in France

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years of age * Physician-reported diagnosis of moderate to severe plaque psoriasis * Be newly initiating deucravacitinib * Do not object to participate Exclusion Criteria: * Currently participating in or planning to participate in an interventional clinical trial * Previous treatment experience with deucravacitinib, including patients who received deucravacitinib as part of a blinded, randomized trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Psoriasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psoriasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    42 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH ARRAS

    RECRUITING

    Arras, 62000, France

  • CH Emile Roux

    RECRUITING

    Le Puy-en-Velay, 43000, France

  • CHU Dijon

    RECRUITING

    Dijon, 21000, France

  • CHU Grenoble Alps, Service de Dermatologie

    RECRUITING

    La Tronche, 38700, France

  • Cabinet Dermatologie

    RECRUITING

    Bordeaux, 33200, France

  • Cabinet Dermatologie

    RECRUITING

    Bordeaux, 33200, France

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Medical

    RECRUITING

    La Chaux-de-Fonds, 2300, Switzerland

  • Cabinet Médical Elisabeth Lion

    RECRUITING

    Angers, 49100, France

  • Cabinet de dermatologie

    RECRUITING

    Paris, 75012, France

  • Centre Dermatologique

    RECRUITING

    Saint-Maur-des-Fossés, 94100, France

  • Centre Hospitalier Lens

    RECRUITING

    Lens, 62307, France

  • Centre Hospitalier William Morey - Hématologie

    RECRUITING

    Chalon-sur-Saône, 71100, France

  • Centre Hospitalier de Roubaix

    RECRUITING

    Roubaix, 59056, France

  • Centre Hospitalier de Roubaix

    RECRUITING

    Roubaix, 59056, France

  • Centre de santé Filieris

    RECRUITING

    Marcq-en-Barœul, 59700, France

  • Ch Georges Renon

    RECRUITING

    Niort, 79021, France

  • Ch Georges Renon

    RECRUITING

    Niort, 79021, France

  • Ch Victor Dupouy

    RECRUITING

    Argenteuil, 95107, France

  • Chu Amiens Picardie - Site Sud

    RECRUITING

    Amiens, 80054, France

  • Hia Begin

    RECRUITING

    Saint-Mandé, 94163, France

  • Hia Sainte Anne

    RECRUITING

    Toulon, 83800, France

  • Hia Sainte Anne

    RECRUITING

    Toulon, 83800, France

  • Hopital Caremeau

    RECRUITING

    Nîmes, 30900, France

  • Hopital Larrey

    RECRUITING

    Toulouse, 31059, France

  • Hopital Larrey

    RECRUITING

    Toulouse, 31059, France

  • Hopital Larrey

    RECRUITING

    Toulouse, 31059, France

  • Hopital Saint Eloi

    RECRUITING

    Montpellier, 34295, France

  • Hopitaux de Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • Hopitaux de Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • Hôpital Privé Francheville

    RECRUITING

    Périgueux, 24000, France

  • Local Institution - 014

    NOT_YET_RECRUITING

    Le Mans, 72037, France

  • Local Institution - 031

    COMPLETED

    Rouen, 76031, France

  • Local Institution - 053

    COMPLETED

    Clermont-Ferrand, 63000, France

  • Local Institution - 056

    COMPLETED

    La Chaux-de-Fonds, 2300, Switzerland

  • Local Institution - 059

    COMPLETED

    La Chaux-de-Fonds, 2300, Switzerland

  • Local Institution - 065

    NOT_YET_RECRUITING

    Saint-Germain-en-Laye, 78100, France

  • Local Institution - 077

    NOT_YET_RECRUITING

    Dijon, 21000, France

  • Local Institution - 086

    COMPLETED

    Paris, 75012, France

  • Local Institution - 089

    COMPLETED

    Argenteuil, 95107, France

  • Médipôle Hôpital Mutualiste

    RECRUITING

    Villeurbanne, 69100, France

  • Médipôle Hôpital Mutualiste

    RECRUITING

    Villeurbanne, 69100, France

  • Tagast 41

    RECRUITING

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.